Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deanna Porras

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|April 23, 2022
Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content ScreeningKinga Vojnits, Mio Nakanishi, Deanna Porras, et al.
Cancer Letters|July 10, 2024
Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugsKinga Vojnits, Zhuohang Feng, Paige Johnson, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|April 23, 2022
Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content ScreeningKinga Vojnits, Mio Nakanishi, Deanna Porras, et al.
Cancer Letters|July 10, 2024
Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugsKinga Vojnits, Zhuohang Feng, Paige Johnson, et al.
Pageof 1